Evidence Following Conditional NICE Technology Appraisal Recommendations: A Critical Analysis of Methods, Quality and Risk of Bias

Yankier Pijeira Perez,Dyfrig A. Hughes
DOI: https://doi.org/10.1007/s40273-024-01418-3
2024-09-10
PharmacoEconomics
Abstract:The National Institute for Health and Care Excellence (NICE) may approve health technologies on condition of more evidence generated only in research (OiR) or only with research (OwR). NICE specifies the information needed to comply with its request, although it may not necessarily guarantee good quality and timely evidence for re-appraisal, before reaching a final decision.
pharmacology & pharmacy,health care sciences & services,health policy & services,economics
What problem does this paper attempt to address?